Back to Search Start Over

Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction

Authors :
Vladimir Stich
Lenka Rossmeislová
Michaela Šiklová
Jana Kračmerová
Eva Klimcakova
Zuzana Kovacova
Jan Polak
Lucia Mališová
Michaela Tencerová
Dominique Langin
Simon, Marie Francoise
Department of Sport Medicine
Charles University [Prague] (CU)
Franco-czech Laboratory for clinical research on obesity
Charles University [Prague] (CU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Laboratoire de Biochimie [CHU Toulouse]
Institut Fédératif de Biologie (IFB)
Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle Biologie [CHU Toulouse]
Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
Institut des Maladies Métaboliques et Cardiovasculaires (I2MC)
Université Toulouse III - Paul Sabatier (UT3)
Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)
Laboratoire de biochimie clinique
CHU Toulouse [Toulouse]
Source :
Journal of Clinical Endocrinology and Metabolism, Journal of Clinical Endocrinology and Metabolism, 2014, 99 (3), pp.E528-35. ⟨10.1210/jc.2013-3348⟩, Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2014, 99 (3), pp.E528-35. ⟨10.1210/jc.2013-3348⟩
Publication Year :
2014

Abstract

Context: Soluble CD163 (sCD163) was suggested as a biomarker of insulin sensitivity and CD163 mRNA expression representing macrophage content in adipose tissue (AT). Objective: The aim of this study was to investigate, in cross-sectional and prospective design, the relationship between sCD163 circulating levels and CD163 mRNA expression in adipose tissue and insulin sensitivity assessed by euglycemic-hyperinsulinemic clamp. Design, Setting, Participants, and Interventions: Two cohorts of subjects were examined in the study. Cohort 1 included 42 women with a wide range of body mass index (17–48 kg/m2); cohort 2 included 27 obese women who followed a dietary intervention consisting of 1 month of a very low-calorie diet and 5 months of a weight-stabilization period. Main Outcome Measures: Serum levels of CD163 and mRNA expression of CD163 and CD68 in sc and visceral (visc) AT were determined, and insulin sensitivity [expressed as glucose disposal rate (GDR)] was measured in cohort 1. In cohort 2, serum levels of CD163, mRNA expressions of CD163, CD68, and CD163-shedding factors [TNF-α-converting enzyme (TACE) and tissue inhibitor of metalloproteinase (TIMP3)] in sc AT were examined and GDR was measured before and during dietary intervention. Results: In cohort 1, circulating sCD163 correlated with CD163 mRNA levels in both sc and visc AT. sCD163 and CD163 mRNA expression in both fat depots correlated with GDR. In cohort 2, the diet-induced changes of sCD163 levels did not correlate with those of CD163, CD68, TACE, and TIMP3 mRNA levels. Although the pattern of the diet-induced change of sCD163 paralleled that of GDR, there was no correlation between the changes of these two variables. Conclusion: sCD163 correlates with CD163 mRNA expression in sc and visc AT and with whole-body insulin sensitivity in the steady-state condition. These associations are not observed with respect to the diet-induced changes during a weight-reducing hypocaloric diet.

Details

ISSN :
19457197 and 0021972X
Volume :
99
Issue :
3
Database :
OpenAIRE
Journal :
The Journal of clinical endocrinology and metabolism
Accession number :
edsair.doi.dedup.....1b4335b105ad4f87ed0ec5773c45aae0
Full Text :
https://doi.org/10.1210/jc.2013-3348⟩